You have 9 free searches left this month | for more free features.

Condition

Congenital Hyperinsulinism (1)

Obese With Comorbidities (1)

Overweight With Comorbidities (1)

Pharmacology (1)

Type2 Diabetes (1)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Hanmi Pharmaceutical Company Limited (3)

Collaborator

Intervention

hm15136 (3)

placebo (1)

placebo of hm15136 (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

hm15136

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pharmacology Trial in Seoul (HM15136, Placebo of HM15136)

Completed

Pharmacology

HM15136
Placebo of HM15136

Seoul, Korea, Republic of

Seoul National University Hospital

Mar 18, 2022

Congenital Hyperinsulinism Trial in Germany, United Kingdom, United States (HM15136)

Recruiting

Congenital Hyperinsulinism

HM15136

Los Angeles, California
+7 more

Sep 26, 2022

Obese With Comorbidities, Overweight With Comorbidities, Type2 Diabetes Trial in San Diego (HM15136, Placebo)

Completed

Obese With Comorbidities
+2 more

HM15136
Placebo

San Diego, California

Prosciento

Apr 1, 2021